Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by ScienceFirston Mar 15, 2023 4:35pm
201 Views
Post# 35340998

RE:RE:I don't understand why...

RE:RE:I don't understand why...Still some insecures, as always?

TLT did what it had to do; reach that 25 patients milestone.  Present to ASCO-GU, and already registered for AUA and published its plan on Jan. 3rd to show what's coming up, mentioned they are engaging into jv discussions with big pharmas in 2023/2024 and still, it's not enough for some!!!

TLT management has more incentives than any of us to make it work.  After all, it's their baby, 20 years of innovation and challenges, pride to make it work, they have shares to incite them to execute, they also invested of their own money, etc ...

We all know what's coming up.  Some are "nervous, insecure".  Hey!  Maybe they're playing FUD to scare some, to buy at lower price.  For example, Gojotv is playing FUD on PYR.  Maybe he changed his short term strategy here too.  60-days + "by end of Q1" is nothing to make anybody nervous, when we're mid-March.   Max. 2.5 months.  For the rest, it's all outside TLT decision and all about FDA decision.  It's not like if we didn't even have clinical data.


<< Previous
Bullboard Posts
Next >>